Status:
COMPLETED
AI-Based Lifestyle Guidance Study
Lead Sponsor:
Li Huating
Conditions:
Diabetes
Eligibility:
All Genders
18-70 years
Phase:
NA
Brief Summary
The X Life model is an innovative AI-based lifestyle guidance system designed to provide tailored health management recommendations for individuals with T2DM or prediabetes, leveraging continuous gluc...
Eligibility Criteria
Inclusion
- Age 18-70 years.
- Prediabetes or Type 2 diabetes mellitus (diagnosed according to recognized clinical criteria).
- Owns and is proficient in using a smartphone with compatible applications.
- Willing and able to wear study devices (CGM, activity tracker).
- Willing to use the X Life model terminal and comply with study procedures.
- Able to understand and provide written informed consent (including participation in interviews).
Exclusion
- Severe chronic diabetic complications or recent acute diabetic complications.
- Early-onset adult T2DM.
- Recent severe hypoglycemic events.
- Cognitive impairment.
- Pregnancy, severe hepatic/renal/thyroid disease, acute infection, psychiatric disorders affecting participation.
- Planned major surgery or treatment likely to significantly impact glucose or weight during the study period.
- Allergy to device materials (CGM sensor, activity tracker, AI terminal).
- Any condition deemed unsuitable by the investigator.
Key Trial Info
Start Date :
September 7 2025
Trial Type :
INTERVENTIONAL
Allocation :
ACTUAL
End Date :
September 30 2025
Estimated Enrollment :
20 Patients enrolled
Trial Details
Trial ID
NCT07160972
Start Date
September 7 2025
End Date
September 30 2025
Last Update
December 2 2025
Active Locations (1)
Enter a location and click search to find clinical trials sorted by distance.
1
Shanghai Sixth People's Hospital
Shanghai, China